Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 3
1998 5
1999 3
2000 1
2001 4
2002 5
2003 3
2004 7
2005 6
2006 5
2007 7
2008 10
2009 2
2010 9
2011 10
2012 20
2013 10
2014 5
2015 18
2016 18
2017 16
2018 14
2019 8
2020 16
2021 9
2022 4
2023 3
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators. Spinner CD, et al. Among authors: ahn my. JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349. JAMA. 2020. PMID: 32821939 Free PMC article. Clinical Trial.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. Marconi VC, et al. Lancet Respir Med. 2021 Dec;9(12):1407-1418. doi: 10.1016/S2213-2600(21)00331-3. Epub 2021 Sep 1. Lancet Respir Med. 2021. PMID: 34480861 Free PMC article. Clinical Trial.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A; GS-US-540-5773 Investigators. Goldman JD, et al. Among authors: ahn my. N Engl J Med. 2020 Nov 5;383(19):1827-1837. doi: 10.1056/NEJMoa2015301. Epub 2020 May 27. N Engl J Med. 2020. PMID: 32459919 Free PMC article. Clinical Trial.
Polyneuropathy After Rapid and Massive Weight Loss.
Kim RO, Lee EJ, Ahn MY, Roh H. Kim RO, et al. Among authors: ahn my. J Clin Neurol. 2023 Mar;19(2):204-206. doi: 10.3988/jcn.2022.0315. J Clin Neurol. 2023. PMID: 36854338 Free PMC article. No abstract available.
Risk assessment of phthalates in pharmaceuticals.
Chung BY, Choi SM, Roh TH, Lim DS, Ahn MY, Kim YJ, Kim HS, Lee BM. Chung BY, et al. Among authors: ahn my. J Toxicol Environ Health A. 2019;82(5):351-360. doi: 10.1080/15287394.2019.1598053. Epub 2019 Apr 8. J Toxicol Environ Health A. 2019. PMID: 30961453
A pseudo-random patient sampling method evaluated.
De La Mata NL, Ahn MY, Kumarasamy N, Ly PS, Ng OT, Nguyen KV, Merati TP, Pham TT, Lee MP, Durier N, Law MG. De La Mata NL, et al. Among authors: ahn my. J Clin Epidemiol. 2017 Jan;81:129-139. doi: 10.1016/j.jclinepi.2016.09.012. Epub 2016 Oct 19. J Clin Epidemiol. 2017. PMID: 27771357 Free PMC article.
201 results